Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |